Joinn Laboratories(China)Co.,Ltd. (HKG:6127)
13.22
+0.08 (0.61%)
Mar 3, 2025, 4:08 PM HKT
HKG:6127 Revenue
Joinn Laboratories(China)Co.,Ltd. had revenue of 485.80M CNY in the quarter ending September 30, 2024, a decrease of -15.51%. This brings the company's revenue in the last twelve months to 2.12B, down -17.61% year-over-year. In the year 2023, Joinn Laboratories(China)Co.,Ltd. had annual revenue of 2.38B with 4.78% growth.
Revenue (ttm)
2.12B CNY
Revenue Growth
-17.61%
P/S Ratio
n/a
Revenue / Employee
846.44K CNY
Employees
2,510
Market Cap
15.46B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.38B | 108.52M | 4.78% |
Dec 31, 2022 | 2.27B | 751.29M | 49.54% |
Dec 31, 2021 | 1.52B | 440.78M | 40.97% |
Dec 31, 2020 | 1.08B | 436.53M | 68.27% |
Dec 31, 2019 | 639.38M | 230.58M | 56.40% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 29.60B |
JD Health International | 58.84B |
Hansoh Pharmaceutical Group Company | 13.00B |
WuXi Biologics | 18.39B |
Alibaba Health Information Technology | 31.39B |
Innovent Biologics | 8.01B |
Akeso | 2.01B |
Sino Biopharmaceutical | 29.86B |